Fort Collins, CO, United States of America

Ehud Zeigerson

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Evonik Corporation. Active years: 2014-2019.


% Patents Active = 100.0


 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Fort Collins, CO (US) (2014)
  • Ft. Collins, CO (US) (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ehud Zeigerson

Introduction

Ehud Zeigerson is an accomplished inventor based in the United States. He has made significant strides in the field of emulsion-based microparticles. His work focuses on developing methods and apparatuses that enhance the production of these microparticles, which can contain biological or chemical agents.

Latest Patents

Ehud Zeigerson holds a patent for "A Method For Production Of Emulsion-Based Microparticles." This invention provides an apparatus and methods that facilitate the production of emulsion-based microparticles. The apparatus includes a vessel and packing material situated inside it, along with materials for enclosing the packing. The methods developed by Zeigerson ensure low-shear, non-turbulent production, resulting in a narrow and reproducible particle size distribution. This innovation is capable of being scaled up conveniently while maintaining predictable emulsion properties.

Career Highlights

Ehud Zeigerson is currently associated with Pr Pharmaceuticals, Inc. His work at the company emphasizes the importance of efficient production methods in the pharmaceutical industry. His contributions have the potential to impact various applications, particularly in drug delivery systems.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Ehud Zeigerson's innovative work in the production of emulsion-based microparticles showcases his commitment to advancing technology in the pharmaceutical field. His contributions are poised to make a significant impact on the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…